Adjuvant small field pelvic radiation for patients with high risk, stage IB lymph node negative cervix carcinoma after radical hysterectomy and pelvic lymph node dissection. A pilot study.
[en] BACKGROUND: After radical hysterectomy and pelvic lymph node dissection, an identifiable subgroup of patients with International Federation of Gynecology and Obstetrics Stage IB lymph node negative cervix carcinoma remains at high risk of pelvic recurrence. This study attempted to determine whether postoperative small field of pelvic radiation can improve the disease free survival (DFS) of this high risk group of patients without producing significant morbidity. METHODS: Between 1991 and 1995, after radical surgery, 25 patients with Stage IB lymph node negative cervix carcinoma were considered to be at high risk of pelvic recurrence on the basis of tumor dimension, depth of stromal invasion, and the presence of lymph-vascular space invasion. All had a score >/= 120 as determined by the Gynecologic Oncology Group (GOG) study. These patients received 50.4 gray of adjuvant radiation to a small central pelvic field and were followed prospectively. A Kaplan-Meier 5-year DFS curve was generated. A log rank analysis produced an estimated log rank P value (est P value) by comparing the 5-year DFS of the patients in the current study with the 5-year DFS of the corresponding high risk group of the GOG study (observation only). The morbidity of small field pelvic radiation was recorded. RESULTS: Among the 25 patients who received small field pelvic radiation, the mean GOG score was 166 (range, 120-263) and the mean follow-up was 32 months (range, 12-64 months). There was 1 recurrence (4%) recorded at 16 months. The log rank analysis demonstrated a significant improvement in the 5-year DFS for the group who received adjuvant small field pelvic radiation (est P value = 0.005) when compared with the DFS of the high risk GOG patients who were observed postoperatively. Four cases of minor morbidity were recorded: lymphedema (three cases) and mild rectal incontinence (one case). No major morbidity was reported. CONCLUSIONS: With low morbidity, adjuvant small field pelvic radiation appears to improve significantly the 5-year DFS of patients with high risk, lymph node negative Stage IB cervical carcinoma. However, this pilot study requires verification.
Disciplines :
Reproductive medicine (gynecology, andrology, obstetrics)
Author, co-author :
KRIDELKA, Frédéric ; Centre Hospitalier Universitaire de Liège - CHU > Gynécologie-Obstétrique
Berg, D. O.
Neuman, M.
Edwards, L. S.
Robertson, G.
Grant, P. T.
Hacker, N. F.
Language :
English
Title :
Adjuvant small field pelvic radiation for patients with high risk, stage IB lymph node negative cervix carcinoma after radical hysterectomy and pelvic lymph node dissection. A pilot study.
Bears OH, Hensen DE, Mutter RP, Myers MH, editors. Manual for staging of cancer. 3rd ed. Philadelphia: J.B. Lippincott, 1988:151-3.
Hacker NF, Wain GV, Nicklin JL. Resection of bulky positive lymph nodes in patients with cervical carcinoma. Int J Gynecol Cancer 1995;5:250-6.
Annual report on the results of treatment in gynecological cancer 1982-1986. Int J Gynecol Obstet 1989;28:189-90.
Morrow CP. Panel report: is pelvic radiation beneficial in the postoperative management of Stage IB squamous cell carcinoma of the cervix with pelvic lymph node metastases treated by radical hysterectomy and pelvic lymphadenectomy? Gynecol Oncol 1980;10:105-10.
Kinney WK, Alvarez RD, Reid GC. Value of adjuvant whole pelvis irradiation after Wertheim hysterectomy for early stage squamous carcinoma of the cervix with pelvic nodal metastasis. A matched control study. Gynecol Oncol 1989; 34:258-62.
Thomas GM, Dembo AJ. Is there a role for adjuvant pelvic radiotherapy after radical hysterectomy in early stage cervical cancer? Int J Gynecol Cancer 1991;1:1-8.
Sartori E, La Face B, Bazzurini L, Fallo L, Pecorelli S, Bianchi UA. Pattern of failure in Stage IB-IIA cervical cancer after radical hysterectomy [abstract 51]. Int J Gynecol Cancer 1995;5(Suppl):15.
Hogan WM, Littman P, Griner L, Cliff RN, Miller L, Mikuta J. Results of radiation therapy given after radical hysterectomy. Cancer 1982;49:1278-85.
Fioricca JV, Roberts WS, Greenberg H, Hoffman MS, LaPolla JP, Cavanagh D. Morbidity and survival patterns in patients after radical hysterectomy and postoperative adjuvant pelvic radiotherapy. Gynecol Oncol 1990;36:343-7.
Takamura A, Mizoe J, Arimoto T, Kamada T, Shirato H, Matsuoka Y, et al. Is postoperative radiotherapy beneficial in the management of Stage I-II squamous cell carcinoma of the uterine cervix with negative metastatic nodes and positive parametrial involvement? A retrospective review of 70 patients. Asia-Oceania J Obstet Gynecol 1993;19(2): 145-51.
Delgado G, Bundy B, Zaino R, Sevin BU, Creasman WT, Major F. Prospective surgical-pathological study of disease-free interval in patients with Stage IB squamous cell carcinoma of the cervix: a Gynecologic Oncology Group study. Gynecol Oncol 1990;38:352-7.
Barter JF, Soong SI, Shingleton HM, Hatch KD, Orr JW. Complications of combined radical hysterectomy and post-operative radiation therapy in women with early stage cervical cancer. Gynecol Oncol 1989;32:292-6.
Cunningham MJ, Dunton CJ, Corn B, Noumoff J, Morgan MA, King S, et al. Extended-field radiation therapy in early-stage cervical carcinoma: survival and complications. Gynecol Oncol 1991;43:51-4.
Sedlis A, Bundy B, Rotman M, Lentz S, Muderspach L, Zaino R. Treatment of selected patients (pts.) with Stage IB carcinoma of the cervix after radical hysterectomy and pelvic lymphadenectomy: pelvic radiation therapy vs. no further therapy. A GOG study. Gynecol Oncol 1998;68:105.